En cuanto la tolerabilidad la evaluacin fue excelente en el 80% (48/60) de los sujetos enrolados, muy bueno en el 15% (9/60) Bueno en el 5% (3/60)
GLP-1s not only show meaningful weight loss long term, but marked improvements in weight-related metabolic conditions, type 2 diabetes, sleep apnea, fatty liver disease and cardiovascular disease, she explained at the discussion about obesity management treatment
Interplay of metabolome and gut microbiome in individuals with major depressive disorder vs control individuals
For patients who are new to self-injection and concerned about the process Direct Meds' included nurse support provides guidance on proper technique, injection site rotation, and managing any local skin reactions that occasionally occur during the first weeks of treatment
But after about six months on the drug, she was 50 pounds lighter